HighTower Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,242
| Closed | -$256K | – | 3307 |
|
|
2023
Q1 | $256K | Sell |
4,242
-743
| -15% | -$44.8K | ﹤0.01% | 2550 |
|
|
2022
Q4 | $364K | Sell |
4,985
-802
| -14% | -$58.6K | ﹤0.01% | 2318 |
|
|
2022
Q3 | $441K | Sell |
5,787
-602
| -9% | -$45.9K | ﹤0.01% | 2089 |
|
|
2022
Q2 | $444K | Sell |
6,389
-731
| -10% | -$50.8K | ﹤0.01% | 2105 |
|
|
2022
Q1 | $592K | Sell |
7,120
-374
| -5% | -$31.1K | ﹤0.01% | 2056 |
|
|
2021
Q4 | $565K | Sell |
7,494
-68
| -0.9% | -$5.13K | ﹤0.01% | 2061 |
|
|
2021
Q3 | $880K | Buy |
7,562
+379
| +5% | +$44.1K | ﹤0.01% | 1730 |
|
|
2021
Q2 | $1.59M | Sell |
7,183
-1,426
| -17% | -$316K | ﹤0.01% | 1364 |
|
|
2021
Q1 | $1.14M | Buy |
8,609
+617
| +8% | +$81.6K | ﹤0.01% | 1483 |
|
|
2020
Q4 | $1.38M | Buy |
7,992
+265
| +3% | +$45.9K | 0.01% | 1087 |
|
|
2020
Q3 | $860K | Sell |
7,727
-1,181
| -13% | -$131K | ﹤0.01% | 1285 |
|
|
2020
Q2 | $529K | Sell |
8,908
-85
| -0.9% | -$5.05K | ﹤0.01% | 1420 |
|
|
2020
Q1 | $605K | Buy |
8,993
+409
| +5% | +$27.5K | ﹤0.01% | 1241 |
|
|
2019
Q4 | $724K | Sell |
8,584
-381
| -4% | -$32.1K | ﹤0.01% | 1277 |
|
|
2019
Q3 | $670K | Sell |
8,965
-1,985
| -18% | -$148K | ﹤0.01% | 1367 |
|
|
2019
Q2 | $693K | Buy |
10,950
+5,530
| +102% | +$350K | ﹤0.01% | 1363 |
|
|
2019
Q1 | $261K | Sell |
5,420
-2,415
| -31% | -$116K | ﹤0.01% | 1790 |
|
|
2018
Q4 | $262K | Sell |
7,835
-10,097
| -56% | -$338K | ﹤0.01% | 1674 |
|
|
2018
Q3 | $938K | Sell |
17,932
-511
| -3% | -$26.7K | 0.01% | 1153 |
|
|
2018
Q2 | $579K | Buy |
18,443
+1,900
| +11% | +$59.6K | ﹤0.01% | 1381 |
|
|
2018
Q1 | $360K | Buy |
+16,543
| New | +$360K | ﹤0.01% | 1587 |
|